Investors
2024 First quarter announcement
We announced our first quarter 2024 results on Wednesday 1 May. Access our first quarter results and latest Annual Report below.
We’re confident in our future
With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.
Speeches and presentations
GSK dividend
GSK share price
Share price tool
Detailed information on GSK's share price, including an interactive chart
Behind the science
Read our latest articles
'Scientists need rich and accessible data at scale to make the best possible impact for patients’
‘We’ve seen an explosion in computing power’: Using AI, machine learning and data to unlock the mysteries of disease
Advanced technology is increasing the chances of improving outcomes for cancer patients
‘Global health progress is vital for millions of lives, but it isn’t going fast enough. Here’s what we need to do to get things back on track’
‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics
‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage
‘Local innovation is vital to our mission to ensure no child is left to suffer from a vaccine preventable disease’
‘It is both a strategic and a moral imperative’: Why closing the health equity gap is better for everyone
‘Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk’
Robots, AI, and machine learning: how smart manufacturing is getting medicines and vaccines from factories to patients faster
